Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 3
2017 2
2018 3
2019 2
2020 2
2022 6
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Validation of a rapid SARS-CoV-2 antibody test in general practice.
Domen J, Verbakel JYJ, Adriaenssens N, Scholtes B, Peeters B, Bruyndonckx R, De Sutter A, Heytens S, Van den Bruel A, Desombere I, Van Damme P, Goossens H, Buret L, Duysburgh E, Coenen S. Domen J, et al. Among authors: buret l. BMJ Open. 2023 May 2;13(5):e069997. doi: 10.1136/bmjopen-2022-069997. BMJ Open. 2023. PMID: 37130685 Free PMC article.
Vaccine Hesitancy towards the COVID-19 Vaccine in a Random National Sample of Belgian Nursing Home Staff Members.
Digregorio M, Van Ngoc P, Delogne S, Meyers E, Deschepper E, Duysburgh E, De Rop L, De Burghgraeve T, Coen A, De Clercq N, Sutter A, Verbakel JY, Cools P, Heytens S, Buret L, Scholtes B. Digregorio M, et al. Among authors: buret l. Vaccines (Basel). 2022 Apr 12;10(4):598. doi: 10.3390/vaccines10040598. Vaccines (Basel). 2022. PMID: 35455347 Free PMC article.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
Adriaenssens N, Scholtes B, Bruyndonckx R, Verbakel JY, De Sutter A, Heytens S, Van den Bruel A, Desombere I, Van Damme P, Goossens H, Buret L, Duysburgh E, Coenen S. Adriaenssens N, et al. Among authors: buret l. BMJ Open. 2022 Jan 31;12(1):e054688. doi: 10.1136/bmjopen-2021-054688. BMJ Open. 2022. PMID: 35105642 Free PMC article.
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.
Meyers E, Deschepper E, Duysburgh E, De Rop L, De Burghgraeve T, Van Ngoc P, Digregorio M, Delogne S, Coen A, De Clercq N, Buret L, Coenen S, Sutter A, Scholtes B, Verbakel JY, Cools P, Heytens S. Meyers E, et al. Among authors: buret l. Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361. Viruses. 2022. PMID: 36366456 Free PMC article.
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Adriaenssens N, Scholtes B, Bruyndonckx R, Van Ngoc P, Verbakel JYJ, De Sutter A, Heytens S, Van Den Bruel A, Desombere I, Van Damme P, Goossens H, Buret L, Duysburgh E, Coenen S. Adriaenssens N, et al. Among authors: buret l. BMJ Open. 2022 Sep 19;12(9):e065897. doi: 10.1136/bmjopen-2022-065897. BMJ Open. 2022. PMID: 36123069 Free PMC article.
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
Meyers E, De Rop L, Deschepper E, Duysburgh E, De Burghgraeve T, Van Ngoc P, Digregorio M, Delogne S, Coen A, De Clercq N, Buret L, Coenen S, De Sutter A, Scholtes B, Verbakel JY, Cools P, Heytens S. Meyers E, et al. Among authors: buret l. Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28. Eur J Gen Pract. 2023. PMID: 36440533 Free PMC article.
25 results